Abstract:BackgroundAn accurate model to stratify breast cancer risk is required to move from a one-size-fits-all screening paradigm to more personalised risk-based screening strategies. Most risk models have limited accuracy and have been calibrated for white women. Considering the rapid increase in breast cancer incidence in China, in this study we aimed to develop a breast cancer model for Chinese women.MethodsWe recruited women from Fudan University Shanghai Cancer Centre. Information about their height, weight, body-mass index, age at menarche, age at first delivery, age at menopause, menopause status, parity history, number of children, breastfeeding history, personal history of breast cancer, family history of breast cancer, and degree of consanguinity was obtained. Mammograms were acquired from all recruited women. We used AutoDensity software to segment the mammographic dense area. To ensure that the breast density had not been affected by presence of the lesion, we measured the mammographic breast density of patients with cancer from the cancer-free breast contralateral to the biopsy-proven cancer. The breast area, dense area, percentage density, and demographic variables were input into an ensemble of 50 decision trees, the results of which we combined using a hybrid sampling and boosting algorithm (RUSBoost). The variables were also fed into the logistic and stepwise logistic regression models, which are two commonly used linear models. Leave-one-out cross-validation was used to assess the performance of the models and the receiver operating characteristics (ROC) curves were generated for each model.FindingsIn total, 1079 women (85 women with biopsy-proven breast cancer and 994 women without breast cancer) were recruited. The classifier had an area under ROC curve (AUC) of 0·86 (95% CI 0·82–0·89) for classifying the cases as normal or high-risk. It outperformed the accuracy of traditionally employed logistic and stepwise logistic regression models, which resulted in AUC values of 0·739 (0·67–0·81) and 0·757 (0·69–0·81), respectively.InterpretationWhen compared with linear models, use of a machine-learning approach, which models data non-linearity, could lead to improvement in the accuracy of a breast cancer risk stratification model. Such a model can be used to recommend intensified surveillance for women at a high risk of future breast cancer.FundingNone.

Enhancing breast cancer screening with urinary biomarkers and Random Forest supervised classification: a comprehensive investigation

Diagnostic Performance of Biomarkers for Bladder Cancer Detection Suitable for Community and Primary Care Settings: A Systematic Review and Meta-Analysis

Quantitative SWATH-based proteomic profiling of urine for the identification of endometrial cancer biomarkers in symptomatic women

Deciphering Urogenital Cancers through Proteomic Biomarkers: A Systematic Review and Meta-Analysis

Analysis of Urinary Metabolites for Breast Cancer Patients Receiving Chemotherapy by Ce-Ms Coupled with On-Line Concentration

Stratifying risk of disease in haematuria patients using machine learning techniques to improve diagnostics

Non-Invasive Endometrial Cancer Screening through Urinary Fluorescent Metabolome Profile Monitoring and Machine Learning Algorithms

Identification of a Novel Biomarker Panel for Breast Cancer Screening

Serum metabolite and metal ions profiles for breast cancer screening

Application of Holistic Liquid Chromatography-High Resolution Mass Spectrometry Based Urinary Metabolomics for Prostate Cancer Detection and Biomarker Discovery

Blood Biomarkers Panels for Screening of Colorectal Cancer and Adenoma on a Machine Learning-Assisted Detection Platform

Discriminating Patients With Early-Stage Breast Cancer From Benign Lesions By Detection Of Oxidative Dna Damage Biomarker In Urine

A Supervised Machine Learning Approach with Feature Selection for Sex-Specific Biomarker Prediction

Urinary-based detection of MSL, HE4 and CA125 as an additional dimension for predictive and prognostic modelling in ovarian cancer

Rapid Detection of Volatile Organic Metabolites in Urine by High-Pressure Photoionization Mass Spectrometry for Breast Cancer Screening: A Pilot Study

Data-Independent Acquisition Mass Spectrometry of EPS-Urine Coupled to Machine Learning: A Predictive Model for Prostate Cancer

Urinary Biomarkers for Prostate Cancer

Comprehensive proteomics and platform validation of urinary biomarkers for bladder cancer diagnosis and staging

A Machine-Learning Approach for Stratifying Breast Cancer Risk in Chinese Women on the Basis of Epidemiological Factors and Mammographic Density

Complete characterization of RNA biomarker fingerprints using a multi-modal ATR-FTIR and SERS approach for label-free early breast cancer diagnosis

Testing breast cancer serum biomarkers for early detection and prognosis in pre-diagnosis samples